---
$id: https://graph.org.ai/products/commodity/51241110
$type: Product
source: UNSPSC
code: "51241110"
title: "Latanoprost"
class: "51241100"
classTitle: "Ophthalmic agents"
family: "51240000"
familyTitle: "Drugs affecting the ears, eye, nose and skin"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Latanoprost

**UNSPSC Code**: 51241110
**Class**: [Ophthalmic agents](Ophthalmic agents.mdx)
**Family**: [Drugs affecting the ears, eye, nose and skin](../Drugs affecting the ears, eye, nose and skin.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a prostaglandin analogue and anti-glaucoma agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6Z5B6HVF6O. European Medicines Agency schedules Latanoprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08409MIG. Latanoprost generally arises in the molecular formula C26H40O5. The term LATANOPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 7, no3, 1993, list 33.) LATANOPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule latanoprost under HS 29375000 and SITC 54156. As of Q4 2014, LATANOPROST remains the US FDA Preferred Term for this commodity. Latanoprost bears US NLM identifiers UMLS ID C0593887 and NCI Concept Code C29151. SMILES: OC1C(C(C(O)C1)C/C=C/CCCC(=O)OC(C)C)CCC(O)CCC1CCCCC1.

